cannabis policy
cannabis policy · page 2
- UK & Europe
What Will ‘Czech Trump’ Mean for the Country’s Cannabis Industry?
The Czech Republic, long considered one of Europe’s most progressive countries on cannabis and wider drug reform, is entering a period of political transition following its parliamentary election earlier this month.
- UK & Europe
Legal Sources Now the First Choice for Cannabis Users in Germany
Since Germany’s Cannabis Act (CanG) came into force on 1 April 2024, much has changed regarding what was once the country’s most widely used illegal drug.
- Medical Cannabis
California Medical Cannabis Home Delivery Bill Vetoed by Governor Newsom
California Governor Gavin Newsom has vetoed legislation that would have allowed certain cannabis microbusinesses to ship medical products directly to patients using common carriers such as FedEx and UPS, citing concerns that the proposed system would be ‘burdensome and overly complex to administer’.
- Uncategorized
Business of Cannabis: New York 2025 – Policy, Investment and Market Growth
At a Glance Date: Thursday, 6 November 2025 Venue: The Wythe Hotel, Williamsburg, New York Attendees: 200+ industry leaders, investors, and policymakers Focus: Regulation, retail strategy, investment, and market growth Tickets: [Purchase here] Where New York’s Cannabis Industry Connects Business of Cannabis: New York returns to The Wythe Hotel on 6 November 2025, bringing together…
- UK & Europe
Spain Becomes Latest European Medical Cannabis Market as First National Rules Given Green Light
First published on Cannabis Health In a landmark decision, Spain’s Council of Ministers has approved a Royal Decree regulating the medical use of cannabis-based preparations in hospital settings, marking the country’s first comprehensive framework for cannabis-derived medicines.
- Medical Cannabis
Import Approvals Paused as Germany Hits 2025 Medical Cannabis Limit
The Federal Institute for Drugs and Medical Devices (BfArM) has announced that Germany’s estimated annual demand for medical cannabis in 2025 has already been reached, leading to a temporary suspension of new import licences.
- Medical Cannabis
German Political Divide Deepens Over Interim Cannabis Report Findings
Last week, Business of Cannabis reported on the publication of Germany’s first official evaluation of its Recreational Cannabis Act (KCanG) and the early data suggesting limited social and health impacts from legalisation.
- Events
UNESCO’s Mondiacult to Spotlight Cannabis in Global Cultural Policy for First Time
For the first time in its history, UNESCO’s flagship cultural policy conference will give cannabis a prominent platform, marking the centenary of its international prohibition and reflecting its growing cultural acceptance.
- Uncategorized
Cannabis Europa 2025 – Key Insights Day 1: Part 2
We’ve summarised the key insights from the vibrant and diverse discussions throughout the second part of Day 1 of Cannabis Europa 2025. If you’re keen to dive into the details, we’ll be exploring each session in more detail over the coming weeks.
- Uncategorized
Cannabis Europa 2025 – Key Insights Day 1: Part 1
Today, Cannabis Europa 2025 welcomed hundreds of the world’s leading cannabis voices for its first jam packed day of sessions.
- Uncategorized
The Future of Cannabis Following the Republican Sweep
Written by Deb Tharp, activist and political consultant. We were on the cusp of full federal recognition of medical cannabis.
- Uncategorized
Last Prisoner Project Receives Justice Rights Award
This Nov 3rd, join us for the third edition of Business of Cannabis: New York at the New York Academy of Medicine.
